CNE000000G05
CNE000000G05
HPGC RENMINTONGTAI PHARMACEUTIC
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 10.378.712.198 | 10.048.279.394 | 3.3% |
| Cost of Revenue | 9.524.655.717 | 9.180.899.980 | 3.7% |
| Gross Profit | 854.056.481 | 867.379.414 | 1.5% |
| 563.605.406 | 543.285.845 | 3.7% | |
| Operating Income | 290.451.074 | 324.093.570 | 10.4% |
| Pretax Income | 189.536.117 | 289.057.623 | 34.4% |
| Net Income Common Stockholders | 133.839.930 | 213.272.260 | 37.2% |
| -- | -- | -- | |
| -- | -- | -- |